Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.0001 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |